rs61744487
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001101426.4(CRPPA):c.346C>T(p.Arg116Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00099 in 1,613,878 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R116H) has been classified as Uncertain significance.
Frequency
Consequence
NM_001101426.4 missense
Scores
Clinical Significance
Conservation
Publications
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- myopathy caused by variation in CRPPAInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive limb-girdle muscular dystrophy type 2UInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- congenital muscular dystrophy without intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRPPA | NM_001101426.4 | c.346C>T | p.Arg116Cys | missense_variant | Exon 2 of 10 | ENST00000407010.7 | NP_001094896.1 | |
CRPPA | NM_001368197.1 | c.346C>T | p.Arg116Cys | missense_variant | Exon 2 of 9 | NP_001355126.1 | ||
CRPPA | NM_001101417.4 | c.346C>T | p.Arg116Cys | missense_variant | Exon 2 of 9 | NP_001094887.1 | ||
CRPPA | NR_160656.1 | n.562C>T | non_coding_transcript_exon_variant | Exon 2 of 8 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00521 AC: 793AN: 152134Hom.: 5 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00128 AC: 320AN: 249070 AF XY: 0.000962 show subpopulations
GnomAD4 exome AF: 0.000550 AC: 804AN: 1461626Hom.: 11 Cov.: 33 AF XY: 0.000469 AC XY: 341AN XY: 727092 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00521 AC: 793AN: 152252Hom.: 5 Cov.: 33 AF XY: 0.00525 AC XY: 391AN XY: 74438 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3
CRPPA: BP4, BS2 -
- -
This variant is associated with the following publications: (PMID: 28688748) -
not specified Benign:1
- -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7;C5190987:Autosomal recessive limb-girdle muscular dystrophy type 2U Benign:1
- -
Congenital Muscular Dystrophy, alpha-dystroglycan related Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at